Arax Advisory Partners’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.9K Buy
579
+100
+21% +$3.97K ﹤0.01% 3803
2026
Q1
$18.4K Hold
479
– – ﹤0.01% 2133
2025
Q4
$19.7K Hold
479
– – ﹤0.01% 2120
2025
Q3
$17.8K Buy
+479
New +$17.4K ﹤0.01% 2317

Other funds holding BME

Arax Advisory Partners's BME Position: Q2 2026 in Review

Arax Advisory Partners increased its BlackRock Health Sciences Trust (BME) stake by 21% in Q2 2026, buying an estimated $3.97K and bringing the position to 579 shares worth $24.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3803.

Arax Advisory Partners first reported a position in BME in Q3 2025 and has held it in 4 quarters since. 78 funds tracked by Wall St. Rank hold BME as of Q2 2026.

  • Arax Advisory Partners held 579 shares of BlackRock Health Sciences Trust worth $24.9K as of Q2 2026.
  • Arax Advisory Partners bought 100 BlackRock Health Sciences Trust shares in Q2 2026, an estimated $3.97K.
  • BlackRock Health Sciences Trust made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3803 holding.
  • Arax Advisory Partners first reported a position in BlackRock Health Sciences Trust in Q3 2025 and has held it in 4 quarters since.
  • 78 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.